|
Vaccine Detail
Rabies virus DNA vaccine encoding the ERA glycoprotein |
Vaccine Information |
- Vaccine Name: Rabies virus DNA vaccine encoding the ERA glycoprotein
- Target Pathogen: Rabies virus
- Target Disease: Rabies
- Vaccine Ontology ID: VO_0004372
- Type: DNA vaccine
- Status: Research
- glycoprotein
gene engineering:
- Type: DNA vaccine construction
- Description: This DNA vaccine expressed the full-length cDNA of the ERA rabies virus glycoprotein (Lodmell et al., 2000).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0000026
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Vaccine Immune Response Type: VO_0000286
- Immune Response: Neutralizing antibody titers were enhanced following primary i.m. vaccination with DNA and MPL® (Lodmell et al., 2000).
- Efficacy: After virus challenge, in the group of mice that were vaccinated with MPL, 4 of 6 mice with individual neutralizing antibody titers of 1:10 survived viral challenge. In addition, in the group of mice that did not receive MPL, 100% of the mice survived viral challenge after their second booster (Lodmell et al., 2000).
|
References |
Lodmell et al., 2000: Lodmell DL, Ray NB, Ulrich JT, Ewalt LC. DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL). Vaccine. 2000; 18(11-12); 1059-1066. [PubMed: 10590326].
|
|